(TPR) Tapestry - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8760301072
Stock: Handbags, Footwear, Jewelry, Leather-Goods, Apparel
Total Rating 70
Risk 55
Buy Signal 1.04
| Risk 5d forecast | |
|---|---|
| Volatility | 38.2% |
| Relative Tail Risk | -10.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.60 |
| Alpha | 63.80 |
| Character TTM | |
|---|---|
| Beta | 1.156 |
| Beta Downside | 1.940 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.54% |
| CAGR/Max DD | 1.43 |
EPS (Earnings per Share)
Revenue
Description: TPR Tapestry March 01, 2026
Tapestry, Inc. (NYSE: TPR) is a multi-brand luxury group that markets accessories, footwear, and ready-to-wear through its three core labels-Coach, Kate Spade, and Stuart Weitzman-via company-owned stores, outlets, e-commerce sites, and shop-in-shop concessions across North America, Greater China, the rest of Asia, and other international markets.
In its most recent fiscal year (FY 2025), Tapestry reported revenue of $6.72 billion, a 5.2% year-over-year increase driven largely by strong comparable-store sales (+4.9%) and a 12% rise in online transactions. Adjusted earnings per share came in at $3.12, while operating margin expanded to 12.5% as the company trimmed inventory days to 68 (down from 78 the prior year) and generated $1.1 billion of free cash flow.
The luxury-apparel sector is being propelled by a rebound in discretionary spending among Chinese consumers-who now account for roughly 28% of Tapestry’s total sales-and by resilient U.S. consumer confidence despite higher interest rates. However, lingering inflationary pressure on raw material costs and a modest slowdown in the U.S. outlet channel remain headwinds that the company is monitoring closely.
For a deeper dive into Tapestry’s valuation metrics, consider checking out ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 522.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 13.93 > 1.0 |
| NWC/Revenue: 14.29% < 20% (prev 15.07%; Δ -0.77% < -1%) |
| CFO/TA 0.27 > 3% & CFO 1.78b > Net Income 522.3m |
| Net Debt (4.12b) to EBITDA (938.8m): 4.39 < 3 |
| Current Ratio: 1.63 > 1.5 & < 3 |
| Outstanding Shares: last quarter (209.8m) vs 12m ago -6.71% < -2% |
| Gross Margin: 75.98% > 18% (prev 0.75%; Δ 7523 % > 0.5%) |
| Asset Turnover: 109.0% > 50% (prev 93.44%; Δ 15.60% > 0%) |
| Interest Coverage Ratio: 12.12 > 6 (EBITDA TTM 938.8m / Interest Expense TTM 60.4m) |
Altman Z'' -0.46
| A: 0.16 (Total Current Assets 2.79b - Total Current Liabilities 1.72b) / Total Assets 6.53b |
| B: -0.50 (Retained Earnings -3.29b / Total Assets 6.53b) |
| C: 0.11 (EBIT TTM 732.0m / Avg Total Assets 6.89b) |
| D: -0.58 (Book Value of Equity -3.49b / Total Liabilities 5.98b) |
| Altman-Z'' Score: -0.46 = B |
Beneish M -3.38
| DSRI: 0.91 (Receivables 569.5m/564.6m, Revenue 7.51b/6.78b) |
| GMI: 0.98 (GM 75.98% / 74.77%) |
| AQI: 0.75 (AQ_t 0.29 / AQ_t-1 0.38) |
| SGI: 1.11 (Revenue 7.51b / 6.78b) |
| TATA: -0.19 (NI 522.3m - CFO 1.78b) / TA 6.53b) |
| Beneish M-Score: -3.38 (Cap -4..+1) = AA |
What is the price of TPR shares?
As of March 01, 2026, the stock is trading at USD 155.47 with a total of 2,840,293 shares traded.
Over the past week, the price has changed by -1.03%, over one month by +21.90%, over three months by +42.76% and over the past year by +87.38%.
Over the past week, the price has changed by -1.03%, over one month by +21.90%, over three months by +42.76% and over the past year by +87.38%.
Is TPR a buy, sell or hold?
Tapestry has received a consensus analysts rating of 4.14.
Therefore, it is recommended to buy TPR.
- StrongBuy: 10
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the TPR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 159.7 | 2.7% |
| Analysts Target Price | 159.7 | 2.7% |
TPR Fundamental Data Overview February 28, 2026
P/E Trailing = 62.2054
P/E Forward = 21.1864
P/S = 4.3706
P/B = 27.8871
P/EG = 0.3711
Revenue TTM = 7.51b USD
EBIT TTM = 732.0m USD
EBITDA TTM = 938.8m USD
Long Term Debt = 2.38b USD (from longTermDebt, last quarter)
Short Term Debt = 331.0m USD (from shortTermDebt, last quarter)
Debt = 5.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.12b USD (from netDebt column, last quarter)
Enterprise Value = 36.97b USD (32.84b + Debt 5.18b - CCE 1.05b)
Interest Coverage Ratio = 12.12 (Ebit TTM 732.0m / Interest Expense TTM 60.4m)
EV/FCF = 21.98x (Enterprise Value 36.97b / FCF TTM 1.68b)
FCF Yield = 4.55% (FCF TTM 1.68b / Enterprise Value 36.97b)
FCF Margin = 22.38% (FCF TTM 1.68b / Revenue TTM 7.51b)
Net Margin = 6.95% (Net Income TTM 522.3m / Revenue TTM 7.51b)
Gross Margin = 75.98% ((Revenue TTM 7.51b - Cost of Revenue TTM 1.80b) / Revenue TTM)
Gross Margin QoQ = 75.46% (prev 76.29%)
Tobins Q-Ratio = 5.66 (Enterprise Value 36.97b / Total Assets 6.53b)
Interest Expense / Debt = 0.34% (Interest Expense 17.4m / Debt 5.18b)
Taxrate = 19.48% (135.8m / 697.1m)
NOPAT = 589.4m (EBIT 732.0m * (1 - 19.48%))
Current Ratio = 1.63 (Total Current Assets 2.79b / Total Current Liabilities 1.72b)
Debt / Equity = 9.39 (Debt 5.18b / totalStockholderEquity, last quarter 551.2m)
Debt / EBITDA = 4.39 (Net Debt 4.12b / EBITDA 938.8m)
Debt / FCF = 2.45 (Net Debt 4.12b / FCF TTM 1.68b)
Total Stockholder Equity = 825.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.58% (Net Income 522.3m / Total Assets 6.53b)
RoE = 63.26% (Net Income TTM 522.3m / Total Stockholder Equity 825.6m)
RoCE = 22.84% (EBIT 732.0m / Capital Employed (Equity 825.6m + L.T.Debt 2.38b))
RoIC = 17.56% (NOPAT 589.4m / Invested Capital 3.36b)
WACC = 8.82% (E(32.84b)/V(38.02b) * Re(10.17%) + D(5.18b)/V(38.02b) * Rd(0.34%) * (1-Tc(0.19)))
Discount Rate = 10.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.84%
[DCF] Terminal Value 76.33% ; FCFF base≈1.35b ; Y1≈1.46b ; Y5≈1.80b
[DCF] Fair Price = 112.2 (EV 26.84b - Net Debt 4.12b = Equity 22.72b / Shares 202.5m; r=8.82% [WACC]; 5y FCF grow 8.95% → 2.90% )
EPS Correlation: 66.78 | EPS CAGR: 55.81% | SUE: 4.0 | # QB: 2
Revenue Correlation: 43.85 | Revenue CAGR: 15.93% | SUE: 4.0 | # QB: 6
EPS next Quarter (2026-03-31): EPS=1.28 | Chg7d=-0.001 | Chg30d=+0.272 | Revisions Net=+14 | Analysts=19
EPS current Year (2026-06-30): EPS=6.50 | Chg7d=+0.086 | Chg30d=+0.861 | Revisions Net=+18 | Growth EPS=+27.4% | Growth Revenue=+11.4%
EPS next Year (2027-06-30): EPS=7.19 | Chg7d=+0.146 | Chg30d=+0.920 | Revisions Net=+17 | Growth EPS=+10.6% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: +1.00 (14 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.6% (Discount Rate 10.2% - Earnings Yield 1.6%)
[Growth] Growth Spread = +3.3% (Analyst 11.9% - Implied 8.6%)
P/E Forward = 21.1864
P/S = 4.3706
P/B = 27.8871
P/EG = 0.3711
Revenue TTM = 7.51b USD
EBIT TTM = 732.0m USD
EBITDA TTM = 938.8m USD
Long Term Debt = 2.38b USD (from longTermDebt, last quarter)
Short Term Debt = 331.0m USD (from shortTermDebt, last quarter)
Debt = 5.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.12b USD (from netDebt column, last quarter)
Enterprise Value = 36.97b USD (32.84b + Debt 5.18b - CCE 1.05b)
Interest Coverage Ratio = 12.12 (Ebit TTM 732.0m / Interest Expense TTM 60.4m)
EV/FCF = 21.98x (Enterprise Value 36.97b / FCF TTM 1.68b)
FCF Yield = 4.55% (FCF TTM 1.68b / Enterprise Value 36.97b)
FCF Margin = 22.38% (FCF TTM 1.68b / Revenue TTM 7.51b)
Net Margin = 6.95% (Net Income TTM 522.3m / Revenue TTM 7.51b)
Gross Margin = 75.98% ((Revenue TTM 7.51b - Cost of Revenue TTM 1.80b) / Revenue TTM)
Gross Margin QoQ = 75.46% (prev 76.29%)
Tobins Q-Ratio = 5.66 (Enterprise Value 36.97b / Total Assets 6.53b)
Interest Expense / Debt = 0.34% (Interest Expense 17.4m / Debt 5.18b)
Taxrate = 19.48% (135.8m / 697.1m)
NOPAT = 589.4m (EBIT 732.0m * (1 - 19.48%))
Current Ratio = 1.63 (Total Current Assets 2.79b / Total Current Liabilities 1.72b)
Debt / Equity = 9.39 (Debt 5.18b / totalStockholderEquity, last quarter 551.2m)
Debt / EBITDA = 4.39 (Net Debt 4.12b / EBITDA 938.8m)
Debt / FCF = 2.45 (Net Debt 4.12b / FCF TTM 1.68b)
Total Stockholder Equity = 825.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.58% (Net Income 522.3m / Total Assets 6.53b)
RoE = 63.26% (Net Income TTM 522.3m / Total Stockholder Equity 825.6m)
RoCE = 22.84% (EBIT 732.0m / Capital Employed (Equity 825.6m + L.T.Debt 2.38b))
RoIC = 17.56% (NOPAT 589.4m / Invested Capital 3.36b)
WACC = 8.82% (E(32.84b)/V(38.02b) * Re(10.17%) + D(5.18b)/V(38.02b) * Rd(0.34%) * (1-Tc(0.19)))
Discount Rate = 10.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.84%
[DCF] Terminal Value 76.33% ; FCFF base≈1.35b ; Y1≈1.46b ; Y5≈1.80b
[DCF] Fair Price = 112.2 (EV 26.84b - Net Debt 4.12b = Equity 22.72b / Shares 202.5m; r=8.82% [WACC]; 5y FCF grow 8.95% → 2.90% )
EPS Correlation: 66.78 | EPS CAGR: 55.81% | SUE: 4.0 | # QB: 2
Revenue Correlation: 43.85 | Revenue CAGR: 15.93% | SUE: 4.0 | # QB: 6
EPS next Quarter (2026-03-31): EPS=1.28 | Chg7d=-0.001 | Chg30d=+0.272 | Revisions Net=+14 | Analysts=19
EPS current Year (2026-06-30): EPS=6.50 | Chg7d=+0.086 | Chg30d=+0.861 | Revisions Net=+18 | Growth EPS=+27.4% | Growth Revenue=+11.4%
EPS next Year (2027-06-30): EPS=7.19 | Chg7d=+0.146 | Chg30d=+0.920 | Revisions Net=+17 | Growth EPS=+10.6% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: +1.00 (14 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.6% (Discount Rate 10.2% - Earnings Yield 1.6%)
[Growth] Growth Spread = +3.3% (Analyst 11.9% - Implied 8.6%)